A 35-year-old woman with BMI 38 kg/m² and no diabetes asks about medications for weight loss. She has hypertension and dyslipidaemia. According to recent Australian recommendations, which of the following is an evidence-based option for pharmacological weight management in addition to lifestyle modification?